Skip to main content
TipRanks
Go Ultimate75% OFF

Profusa (PFSA) Stock Price & Analysis

110 Followers

PFSA Stock Chart & Stats

$0.45-$0.01(-2.61%)
At close: 4:00 PM EST
$0$10$20Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$0.40 - $0.49
52-Week Range
$0.40 - $1,539.09
Previous Close
$0.46
Volume
N/A
Average Volume (3M)
2.05M
Market Cap
$271.33K
Enterprise Value
$13.96M
Total Cash (Recent Filing)
$339.00K
Total Debt (Recent Filing)
$6.47M
Price to Earnings (P/E)
―
Beta
1.20
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Biosensor Platform

The tissue-integrated sensor platform addresses continuous, real-time physiological monitoring through an implantable device and external reader. Its potential applications across health monitoring and performance tracking provide multiple commercialization pathways if the technology advances into broader product adoption.

Improved Capital Structure

Exchanging approximately $6.14 million of secured notes into preferred equity reduces the company’s secured debt burden and shifts a creditor claim toward equity exposure. That change can improve capital-structure flexibility and reduce immediate repayment pressure, although ownership concentration remains relevant.

Nasdaq Compliance Restored

Regaining compliance with Nasdaq’s bid-price and equity requirements preserves the company’s exchange listing and access to public-market infrastructure. Maintaining that status supports continued trading visibility and financing access, although the one-year monitoring period means compliance remains an ongoing requirement.

Bears Say

No Revenue And Widening Losses

The absence of reported revenue across periods indicates that commercialization has not yet produced measurable operating scale. At the same time, the much larger TTM loss shows deteriorating earnings performance, leaving the business dependent on future product progress and external capital to reach profitability.

Persistent Cash Burn

Deeply negative operating and free cash flow show that current activities consume cash rather than fund themselves. Continued cash burn limits internal reinvestment capacity and increases the need for financing while the company works toward commercialization, making execution and liquidity important medium-term constraints.

Secured Convertible Financing

The new secured convertible note demonstrates continued reliance on creditor financing and adds obligations that can restrict financial flexibility. Asset security prioritizes the lender, while equity conversion and stock-based interest or amortization payments create potential dilution for shareholders if additional funding remains necessary.

Profusa News

PFSA FAQ

What was Profusa’s price range in the past 12 months?
Profusa lowest stock price was $0.40 and its highest was $1539.09 in the past 12 months.
What is Profusa’s market cap?
Profusa’s market cap is $271.33K.
When is Profusa’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Profusa’s earnings last quarter?
Profusa released its earnings results on Aug 20, 2026. The company reported -$151.796 earnings per share for the quarter.
Is Profusa overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Profusa pay dividends?
Profusa does not currently pay dividends.
What is Profusa’s EPS estimate?
Profusa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Profusa have?
Profusa has 605,647 shares outstanding.
What happened to Profusa’s price movement after its last earnings report?
Profusa reported an EPS of -$151.796 in its last earnings report. Following the earnings report the stock price went down -44.215%.
Which hedge fund is a major shareholder of Profusa?
Currently, no hedge funds are holding shares in PFSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology